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Non-specific “non-effects” of vaccination
Literature does not support either beneficial or detrimental effects
This issue carries a paper from Burkina Faso onthe non-specific effects of vaccination onsurvival in children (p1309).1 The study
analyses mortality in a cohort of children as a function
of their vaccination status. The authors conclude that
vaccination with diphtheria, tetanus, and pertussis
(DTP) vaccine as well as BCG is associated with better
survival of children up to 2 years of age.” The paper
should be viewed with caution and in context.
Non-specific effects of vaccination, beneficial or det-
rimental, have been discussed for about 15 years. Some
vaccines have effects on non-target diseases—for
example, BCG protects against leprosy.2 Some vaccines
have rare adverse reactions—for example,myopericardi-
tis following smallpox vaccine.3 High titre measles
vaccines were evaluated in the 1980s and withdrawn
because of a hint of unexpected mortality in vaccinated
girls.4 This observation stemmed from work by Aaby et
al and led to a series of publications linking morbidity
and mortality patterns to vaccination in several popula-
tions, particularly inWest Africa. BCG and standard titre
measles vaccines were claimed to be more beneficial
than could be explained by their effects on tuberculosis
or measles alone.5 6 Associations found in one popula-
tion were not always upheld in other populations.7
Hypotheses shifted, and the higher mortality once
attributed to high titre measles vaccines was later attrib-
uted to alterations in the DTP schedule.8 In 2000, the
BMJ published a paper based on data from Guinea-
Bissau, which claimed that diphtheria, tetanus, pertussis,
and polio vaccines were associated with higher infant
mortality.9 That report encouraged a series of studies, of
which the paper by Vaugelade et al in this issue is one.
An independent WHO task force also reviewed all the
data and concluded that the finding fromGuinea-Bissau
relating to DPT was not convincing.10
The problem with literature on this subject has
been the reliance on observational studies comparing
non-comparable populations—non-comparable because
vaccinated individuals are different in all populations
and in many ways from those who are not vaccinated.11
The paper by Vaugelade et al illustrates this
problem well.1 The data on vaccination were tran-
scribed from individual health cards of the children in
the context of a demographic surveillance system. Vac-
cination coverage was low—55% had apparently
received no vaccines at all by 6 months of age, and 24%
were totally unvaccinated at 2 years. Confounding is
obvious, as vaccination was associated strongly with
high maternal age, modern obstetric delivery, and
presence of a dispensary in the village (such
associations are expected). The authors assumed that
absence of a vaccination record meant no vaccination.
They also say that when a child died, the mother
usually discarded its belongings, including vaccination
details. Selective misclassification could therefore have
occurred—towards unvaccinated status in children who
died. The proportion of infants who had cards at
successive visits and consistency of data from one visit
to the next are not discussed in the paper. People with
experience of such data will know how problematic
they are. Diarrhoea, fever, and cough in infancy were
all associated significantly with vaccination (table 2 in
the paper1). As it is unlikely that the vaccines caused
this morbidity, it probably means that sick children
were brought to the clinic and hence selectively
vaccinated, and lost cards may have been replaced
when ill children visited health centres.
The mortality analyses adjusted for potential
confounders on which data were available, but the study
was not designed for this purpose and there were no
data on factors such as parental education, occupation,
or economic status. The conclusion that lower mortality
was associated with both the BCG vaccine and the DTP
vaccine may be technically correct, but this may be mis-
leading in conjunction with the word effect in the title of
the paper. Critical readers will interpret the greatly lower
mortality (by 50-75 %) as largely if not entirely a reflec-
tion of uncontrolled socioeconomic advantages of the
children receiving the vaccines.
The only conclusion justified by this study is that
analysis of very problematic data showed no evidence
for a positive association between any vaccine and
increased mortality in infants. That in itself is
reassuring; but it is a long way from saying that the vac-
cines have non-specific beneficial or detrimental
effects. This criticism may be directed at much of the
literature on this subject.5–10
Are hypotheses of non-specific effects of vaccines
tenable or can we study them at all? One problem is that
the hypotheses have kept changing, from one to another
subgroup effect on mortality, allergic disease, immune
response, Gulf war syndrome, or to qualifications that
they may be important only in populations subject to a
major challenge from infectious disease.Hypotheses are
cheap to manufacture but difficult to test, given the non-
random allocation of vaccines in routine programmes.
Evidence shows that vaccination with some antigens (for
example, BCG) can influence responses to other
antigens (for example, hepatitis B),12 but we have no
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convincing evidence that this has any implications for
subsequent morbidity let alone mortality.
If we had serious concern over such effects, the best
way to evaluate them would be by large cluster
randomised trials of different vaccine formulations, or
of standard vaccines given according to different
schedules. We could contemplate such trials for
reasons of overall direct as well as indirect effects. The
standard vaccines change over time, and the most
widely used timetable (BCG/oral polio vaccine at birth,
DTP/OPV at 6, 10, and 14 weeks of age, measles after
9 months) was set 30 years ago at the start of the World
Health Organization’s expanded programme on
immunisation as an optimal compromise considering
the vaccines then in use, the disease risks then prevail-
ing, and logistic considerations concerning paediatric
clinic policies for children of that era. But much has
changed—new vaccines and vaccine formulations, low-
ered disease risks (largely due to widespread vaccina-
tion), and changed child health regimens, which now
include micronutrients in many countries. We may
need to reconsider the optimal basic schedule for
delivery of vaccines and other services to the world’s
children, and we need to evaluate them if possible with
trials—not with observational studies with biased data.
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Suicide pacts and the internet
Complete strangers may make cyberspace pacts
The recent deaths of nine people in Japan, inOctober 2004, apparently in two suicidepacts1—seven suicides in one pact and two in
the other—have brought the relatively rare phenom-
enon of suicide pacts into the limelight. What is
unusual is that these pacts seem to have been arranged
between strangers who met over the internet and
planned the tragedy via special suicide websites. This is
in contrast to traditional suicide pacts, in which the vic-
tims are people with close relationships.
A suicide pact is an agreement between two or
more people to commit suicide together at a given
place and time. In England and Wales, for epidemio-
logical purposes, people who have committed suicide
within three days of each other in the same registration
subdistrict are considered potential victims of a suicide
pact.2 A related phenomenon is homicide-suicide, in
which a person commits a murder and then ends his or
her own life. Dyadic death is a term that encompasses
both suicide pacts and homicide-suicides.3 A suicide
cluster is a group of suicides that occur closer together
in time and space than would normally be expected in
a given community, with suicides occurring later in the
cluster being motivated by earlier suicides. In mass
suicide, several people commit suicide usually influ-
enced by charismatic leadership, strong loyalties, or
religious beliefs.
Two major epidemiological studies on suicide pacts
have been carried out in England and Wales, 36 years
apart.2 4 The second study showed that the incidence of
suicide pacts had declined by 27% in that period.2 On
average, one suicide pact occurs every month. Suicide
pacts almost always involve people well known to each
other, mostly spouses, most of them childless. Most of
the victims belong to social classes I, II, and III, and a
noteworthy proportion work in professions allied to
medicine. The methods used are generally less violent;
poisoning by exhaust fumes from a vehicle is the most
common. But where access to violent means is easier,
such as firearms in the United States, suicide pacts
entail more violent methods.5 Most victims leave jointly
signed suicide notes.
Although, by definition, both victims make a joint
decision to die in a suicide pact, studies of survivors of
pacts have shown that this is not always the case.6 In
cases where the decision was not mutual, the deceased
member is likely to have been the instigator, male,
depressed, and to have had a history of self harm,
whereas the survivor is likely to be the coerced, female,
not mentally ill, and with no previous history of self
harm.
Suicide pacts account for less than 1% of the total
number of suicides.2 4 Both members typically employ
the same method. Occasionally, the partners may
both use multiple methods to ensure death.7 About
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